_id
69235aaab93c8af7a393e3fa
Ticker
SBFMW
Name
Sunshine Biopharma Inc. Warrant
Exchange
NASDAQ
Address
333 Las Olas Way, Fort Lauderdale, FL, United States, 33301
Country
USA
Sector
Industry
Currency
USD
Website
https://sunshinebiopharma.com
Description
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Last Close
0.2428
Volume
1368
Current Price
0.1801
Change
-0.0174
Last Updated
2026-01-06T10:46:24.722Z
Image
https://logo.clearbit.com/sunshinebiopharma.com
Ipo Date
2022-02-15T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
9417179
Cost Of Revenue
6343639
Gross Profit
3073540
Operating Expenses
4160153
Operating Income
-1086613
Interest Expense
0
Pretax Income
-1021258
Net Income
-883820
Eps
-0.1900000085990364
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-137438
EBITDA
-925095
Operating Margin
-11.538625314438644
Total Other Income Expense Net
65355
Cash
9306438
Short Term Investments
-
Receivables
4155598
Inventories
14063706
Total Current Assets
27967232
Property Plant Equipment
1418576
Total Assets
31487379
Payables
6137465
Short Term Debt
436106
Long Term Debt
-
Total Liabilities
7288023
Equity
24199356
Bs_currency_symbol
USD
Depreciation
96163
Change In Working Capital
-494793
Cash From Operations
-727800
Capital Expenditures
8040
Cash From Investing
-118295
Cash From Financing
75536
Net Change In Cash
-998882
Cf_currency_symbol
USD
PE
-
PB
0.0346194455918579
ROE
-3.652245952330302
ROA
-2.8069024100100552
FCF
-735840
Fcf Percent
-0.07813804962186659
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
9417179
Quarters > 0 > income Statement > cost Of Revenue
6343639
Quarters > 0 > income Statement > gross Profit
3073540
Quarters > 0 > income Statement > operating Expenses
4160153
Quarters > 0 > income Statement > operating Income
-1086613
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-1021258
Quarters > 0 > income Statement > net Income
-883820
Quarters > 0 > income Statement > eps
-0.1900000085990364
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4651684
Quarters > 0 > income Statement > income Tax Expense
-137438
Quarters > 0 > income Statement > EBITDA
-925095
Quarters > 0 > income Statement > operating Margin
-11.538625314438644
Quarters > 0 > income Statement > total Other Income Expense Net
65355
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
9306438
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
4155598
Quarters > 0 > balance Sheet > inventories
14063706
Quarters > 0 > balance Sheet > total Current Assets
27967232
Quarters > 0 > balance Sheet > property Plant Equipment
1418576
Quarters > 0 > balance Sheet > total Assets
31487379
Quarters > 0 > balance Sheet > payables
6137465
Quarters > 0 > balance Sheet > short Term Debt
436106
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7288023
Quarters > 0 > balance Sheet > equity
24199356
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-883820
Quarters > 0 > cash Flow > depreciation
96163
Quarters > 0 > cash Flow > change In Working Capital
-494793
Quarters > 0 > cash Flow > cash From Operations
-727800
Quarters > 0 > cash Flow > capital Expenditures
8040
Quarters > 0 > cash Flow > cash From Investing
-118295
Quarters > 0 > cash Flow > cash From Financing
75536
Quarters > 0 > cash Flow > net Change In Cash
-998882
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.1900000085990364
Quarters > 0 > ratios > PB
0.0346194455918579
Quarters > 0 > ratios > ROE
-3.652245952330302
Quarters > 0 > ratios > ROA
-2.8069024100100552
Quarters > 0 > ratios > FCF
-735840
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.07813804962186659
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
9410230
Quarters > 1 > income Statement > cost Of Revenue
5987364
Quarters > 1 > income Statement > gross Profit
3422866
Quarters > 1 > income Statement > operating Expenses
5477521
Quarters > 1 > income Statement > operating Income
-2054655
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-1980000
Quarters > 1 > income Statement > net Income
-1770834
Quarters > 1 > income Statement > eps
-7.877200240208181
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
224805
Quarters > 1 > income Statement > income Tax Expense
-209166
Quarters > 1 > income Statement > EBITDA
-1907467
Quarters > 1 > income Statement > operating Margin
-21.83426972560713
Quarters > 1 > income Statement > total Other Income Expense Net
74655
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
10305320
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
3587560
Quarters > 1 > balance Sheet > inventories
13018702
Quarters > 1 > balance Sheet > total Current Assets
27851018
Quarters > 1 > balance Sheet > property Plant Equipment
1531172
Quarters > 1 > balance Sheet > total Assets
31965250
Quarters > 1 > balance Sheet > payables
4797465
Quarters > 1 > balance Sheet > short Term Debt
222496
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
6280446
Quarters > 1 > balance Sheet > equity
25684804
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1770834
Quarters > 1 > cash Flow > depreciation
72533
Quarters > 1 > cash Flow > change In Working Capital
-636940
Quarters > 1 > cash Flow > cash From Operations
-1273432
Quarters > 1 > cash Flow > capital Expenditures
550187
Quarters > 1 > cash Flow > cash From Investing
-491778
Quarters > 1 > cash Flow > cash From Financing
3610235
Quarters > 1 > cash Flow > net Change In Cash
2180710
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-7.877200240208181
Quarters > 1 > ratios > PB
0.0015763165060554871
Quarters > 1 > ratios > ROE
-6.894481266043533
Quarters > 1 > ratios > ROA
-5.539872204972587
Quarters > 1 > ratios > FCF
-1823619
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.19379111881431166
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
8901000
Quarters > 2 > income Statement > cost Of Revenue
6171000
Quarters > 2 > income Statement > gross Profit
2730000
Quarters > 2 > income Statement > operating Expenses
4026000
Quarters > 2 > income Statement > operating Income
-1296000
Quarters > 2 > income Statement > interest Expense
8529
Quarters > 2 > income Statement > pretax Income
-1220000
Quarters > 2 > income Statement > net Income
-1180000
Quarters > 2 > income Statement > eps
-0.43655197928227896
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
2703000
Quarters > 2 > income Statement > income Tax Expense
-40161
Quarters > 2 > income Statement > EBITDA
-1155000
Quarters > 2 > income Statement > operating Margin
-14.560161779575328
Quarters > 2 > income Statement > total Other Income Expense Net
75818
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
8124610
Quarters > 2 > balance Sheet > short Term Investments
70457
Quarters > 2 > balance Sheet > receivables
3445242
Quarters > 2 > balance Sheet > inventories
11857135
Quarters > 2 > balance Sheet > total Current Assets
24480980
Quarters > 2 > balance Sheet > property Plant Equipment
1420677
Quarters > 2 > balance Sheet > total Assets
29187105
Quarters > 2 > balance Sheet > payables
5024541
Quarters > 2 > balance Sheet > short Term Debt
213983
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6484635
Quarters > 2 > balance Sheet > equity
22702470
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1179771
Quarters > 2 > cash Flow > depreciation
64793
Quarters > 2 > cash Flow > change In Working Capital
-598857
Quarters > 2 > cash Flow > cash From Operations
-1713835
Quarters > 2 > cash Flow > capital Expenditures
212017
Quarters > 2 > cash Flow > cash From Investing
-176024
Quarters > 2 > cash Flow > cash From Financing
338137
Quarters > 2 > cash Flow > net Change In Cash
-1561919
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.43655197928227896
Quarters > 2 > ratios > PB
0.021443054434165096
Quarters > 2 > ratios > ROE
-5.197672323760366
Quarters > 2 > ratios > ROA
-4.042881265545178
Quarters > 2 > ratios > FCF
-1925852
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.21636355465678014
Quarters > 2 > health Score
33
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
9594992
Quarters > 3 > income Statement > cost Of Revenue
6501943
Quarters > 3 > income Statement > gross Profit
3093049
Quarters > 3 > income Statement > operating Expenses
11632714
Quarters > 3 > income Statement > operating Income
-2037722
Quarters > 3 > income Statement > interest Expense
8529
Quarters > 3 > income Statement > pretax Income
-2286949
Quarters > 3 > income Statement > net Income
-2158212
Quarters > 3 > income Statement > eps
-0.8364845056273056
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2580098
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-21.237349650734465
Quarters > 3 > income Statement > total Other Income Expense Net
-340003
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
9686529
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
3868418
Quarters > 3 > balance Sheet > inventories
11278105
Quarters > 3 > balance Sheet > total Current Assets
25966349
Quarters > 3 > balance Sheet > property Plant Equipment
1482092
Quarters > 3 > balance Sheet > total Assets
30560392
Quarters > 3 > balance Sheet > payables
5543085
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
7059638
Quarters > 3 > balance Sheet > equity
23500754
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2158210
Quarters > 3 > cash Flow > depreciation
65399
Quarters > 3 > cash Flow > change In Working Capital
937565
Quarters > 3 > cash Flow > cash From Operations
-3407282
Quarters > 3 > cash Flow > capital Expenditures
439304
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2053989
Quarters > 3 > cash Flow > net Change In Cash
-1884828
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.8364845056273056
Quarters > 3 > ratios > PB
0.019772797494071893
Quarters > 3 > ratios > ROE
-9.183586194723794
Quarters > 3 > ratios > ROA
-7.062121454463019
Quarters > 3 > ratios > FCF
-3846586
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.40089517531645674
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
34874000
Annuals > 0 > income Statement > cost Of Revenue
24204000
Annuals > 0 > income Statement > gross Profit
10670000
Annuals > 0 > income Statement > operating Expenses
16482000
Annuals > 0 > income Statement > operating Income
-5812000
Annuals > 0 > income Statement > interest Expense
8774
Annuals > 0 > income Statement > pretax Income
-5369000
Annuals > 0 > income Statement > net Income
-5134000
Annuals > 0 > income Statement > eps
-7.316006150347204
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
701749
Annuals > 0 > income Statement > income Tax Expense
-235000
Annuals > 0 > income Statement > EBITDA
-5154000
Annuals > 0 > income Statement > operating Margin
-16.665710844755406
Annuals > 0 > income Statement > total Other Income Expense Net
443147
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
9686529
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
3868418
Annuals > 0 > balance Sheet > inventories
11278105
Annuals > 0 > balance Sheet > total Current Assets
25966349
Annuals > 0 > balance Sheet > property Plant Equipment
1482092
Annuals > 0 > balance Sheet > total Assets
30560392
Annuals > 0 > balance Sheet > payables
5543085
Annuals > 0 > balance Sheet > short Term Debt
207756
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
7059638
Annuals > 0 > balance Sheet > equity
23500754
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-5134116
Annuals > 0 > cash Flow > depreciation
223527
Annuals > 0 > cash Flow > change In Working Capital
-5380557
Annuals > 0 > cash Flow > cash From Operations
-12531180
Annuals > 0 > cash Flow > capital Expenditures
2320847
Annuals > 0 > cash Flow > cash From Investing
-2320847
Annuals > 0 > cash Flow > cash From Financing
9289507
Annuals > 0 > cash Flow > net Change In Cash
-6605818
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-7.316006150347204
Annuals > 0 > ratios > PB
0.005153957077292074
Annuals > 0 > ratios > ROE
-21.84610757595267
Annuals > 0 > ratios > ROA
-16.799522728635154
Annuals > 0 > ratios > FCF
-14852027
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.42587678499741927
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
24093000
Annuals > 1 > income Statement > cost Of Revenue
15754000
Annuals > 1 > income Statement > gross Profit
8339000
Annuals > 1 > income Statement > operating Expenses
13124000
Annuals > 1 > income Statement > operating Income
-4785000
Annuals > 1 > income Statement > interest Expense
137308
Annuals > 1 > income Statement > pretax Income
-4111000
Annuals > 1 > income Statement > net Income
-4506000
Annuals > 1 > income Statement > eps
-370.4069050554871
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
12165
Annuals > 1 > income Statement > income Tax Expense
395166
Annuals > 1 > income Statement > EBITDA
-3824000
Annuals > 1 > income Statement > operating Margin
-19.860540405927033
Annuals > 1 > income Statement > total Other Income Expense Net
674422
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
16292347
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
2552362
Annuals > 1 > balance Sheet > inventories
5734755
Annuals > 1 > balance Sheet > total Current Assets
24890055
Annuals > 1 > balance Sheet > property Plant Equipment
1012647
Annuals > 1 > balance Sheet > total Assets
27346961
Annuals > 1 > balance Sheet > payables
2585466
Annuals > 1 > balance Sheet > short Term Debt
118670
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
6139600
Annuals > 1 > balance Sheet > equity
21207361
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4506044
Annuals > 1 > cash Flow > depreciation
149147
Annuals > 1 > cash Flow > change In Working Capital
-4418214
Annuals > 1 > cash Flow > cash From Operations
-8775111
Annuals > 1 > cash Flow > capital Expenditures
788099
Annuals > 1 > cash Flow > cash From Investing
-656150
Annuals > 1 > cash Flow > cash From Financing
3425587
Annuals > 1 > cash Flow > net Change In Cash
-5534090
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-370.4069050554871
Annuals > 1 > ratios > PB
0.00009900708532287444
Annuals > 1 > ratios > ROE
-21.247339544038507
Annuals > 1 > ratios > ROA
-16.477150788345366
Annuals > 1 > ratios > FCF
-9563210
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.39692898352218486
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
4346000
Annuals > 2 > income Statement > cost Of Revenue
2649000
Annuals > 2 > income Statement > gross Profit
1697000
Annuals > 2 > income Statement > operating Expenses
10371000
Annuals > 2 > income Statement > operating Income
-27001000
Annuals > 2 > income Statement > interest Expense
39412
Annuals > 2 > income Statement > pretax Income
-26511000
Annuals > 2 > income Statement > net Income
-26744000
Annuals > 2 > income Statement > eps
-3523.5836627140975
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
7590
Annuals > 2 > income Statement > income Tax Expense
233304
Annuals > 2 > income Statement > EBITDA
-26447000
Annuals > 2 > income Statement > operating Margin
-621.2839392544869
Annuals > 2 > income Statement > total Other Income Expense Net
489614
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
21826437
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1912153
Annuals > 2 > balance Sheet > inventories
3289945
Annuals > 2 > balance Sheet > total Current Assets
27312334
Annuals > 2 > balance Sheet > property Plant Equipment
1154658
Annuals > 2 > balance Sheet > total Assets
29545141
Annuals > 2 > balance Sheet > payables
2802796
Annuals > 2 > balance Sheet > short Term Debt
123026
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
7917571
Annuals > 2 > balance Sheet > equity
21627570
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-26744440
Annuals > 2 > cash Flow > depreciation
25163
Annuals > 2 > cash Flow > change In Working Capital
3154504
Annuals > 2 > cash Flow > cash From Operations
-5248358
Annuals > 2 > cash Flow > capital Expenditures
304997
Annuals > 2 > cash Flow > cash From Investing
-14619390
Annuals > 2 > cash Flow > cash From Financing
39465107
Annuals > 2 > cash Flow > net Change In Cash
19781270
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-3523.5836627140975
Annuals > 2 > ratios > PB
0.00006057240827332891
Annuals > 2 > ratios > ROE
-123.65698041897448
Annuals > 2 > ratios > ROA
-90.51911446284856
Annuals > 2 > ratios > FCF
-5553355
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-1.2778083294983893
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
228426
Annuals > 3 > income Statement > cost Of Revenue
117830
Annuals > 3 > income Statement > gross Profit
110596
Annuals > 3 > income Statement > operating Expenses
2551000
Annuals > 3 > income Statement > operating Income
-2440000
Annuals > 3 > income Statement > interest Expense
328818
Annuals > 3 > income Statement > pretax Income
-12436000
Annuals > 3 > income Statement > net Income
-12436000
Annuals > 3 > income Statement > eps
-9522.205206738132
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1306
Annuals > 3 > income Statement > income Tax Expense
328818
Annuals > 3 > income Statement > EBITDA
-12095000
Annuals > 3 > income Statement > operating Margin
-1068.1796292891352
Annuals > 3 > income Statement > total Other Income Expense Net
-9996000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2045167
Annuals > 3 > balance Sheet > short Term Investments
7590
Annuals > 3 > balance Sheet > receivables
7798
Annuals > 3 > balance Sheet > inventories
105650
Annuals > 3 > balance Sheet > total Current Assets
2195830
Annuals > 3 > balance Sheet > property Plant Equipment
7061
Annuals > 3 > balance Sheet > total Assets
2202891
Annuals > 3 > balance Sheet > payables
42942
Annuals > 3 > balance Sheet > short Term Debt
1900000
Annuals > 3 > balance Sheet > long Term Debt
1900000
Annuals > 3 > balance Sheet > total Liabilities
1991229
Annuals > 3 > balance Sheet > equity
211662
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-12436447
Annuals > 3 > cash Flow > depreciation
12741
Annuals > 3 > cash Flow > change In Working Capital
-108797
Annuals > 3 > cash Flow > cash From Operations
-1829128
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
2904675
Annuals > 3 > cash Flow > net Change In Cash
1055279
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-9522.205206738132
Annuals > 3 > ratios > PB
0.0010649790704047018
Annuals > 3 > ratios > ROE
-5875.405127042171
Annuals > 3 > ratios > ROA
-564.5308823723008
Annuals > 3 > ratios > FCF
-1829128
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-8.007529790829416
Annuals > 3 > health Score
16
Valuation > metrics > PE
-0.1900000085990364
Valuation > metrics > PB
0.0346194455918579
Valuation > final Score
70
Valuation > verdict
96.5% Undervalued
Profitability > metrics > ROE
-3.652245952330302
Profitability > metrics > ROA
-3.16019833496572
Profitability > metrics > Net Margin
-0.09385188494346343
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.30116598970650293
Risk > metrics > Interest Coverage
-11.299699468610589
Risk > final Score
15
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.254496072226192
Liquidity > metrics > Quick Ratio
2.1150643995478258
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-53
Prev Risks > 1
-548
Prev Risks > 2
-896
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-22T21:22:41.347Z
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ALayoff Watch: What is the dividend yield of ALTO - Portfolio Performance Report & Community Consensus Stock Picks baoquankhu1.vn
Read more →Will SBFMW stock recover after earnings - Quarterly Earnings Review & Invest Now – Opportunity Window Closing bollywoodhelpline.com
Read more →Showing 2 of 8
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Sunshine Biopharma Inc. Warrant
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.